To hear about similar clinical trials, please enter your email below
Trial Title:
Exploring the Application of 3D Bioprinting for Personalized Treatment in Pancreatic Ductal Adenocarcinoma
NCT ID:
NCT05955092
Condition:
Pancreatic Ductal Adenocarcinoma
Conditions: Official terms:
Adenocarcinoma
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Cross-Sectional
Summary:
The goal of this observational study is to test the application value of 3D bioprinting
technology in personalized treatment of pancreatic cancer.
The main questions it aims to answer are:
- Can 3D bioprinting technology be successfully applied to establish preclinical
models of pancreatic cancer?
- Can 3D bioprinted preclinical models of pancreatic cancer be applied to personalized
treatment of pancreatic cancer?
Participants will have tumor tissue collected to extract primary tumor cells for the
establishment of in vitro preclinical models, which will be used for drug sensitivity
testing.
Criteria for eligibility:
Study pop:
The patients with clinically and pathologically confirmed pancreatic ductal
adenocarcinoma are considered potential candidates for this study. Clinical physicians
will comprehensively document the medical history, including only patients above 18 years
of age. Individuals with other malignant tumors or severe diseases will be excluded.
Patients who are unable to provide independent informed consent will not be included in
this study. All patients in this study will undergo adjuvant/neoadjuvant chemotherapy and
surgical resection for the treatment of localized pancreatic ductal adenocarcinoma.
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- More than 18 years old
- Diagnosed as colorectal cancer with or without liver metastases before
- Pathologically proven colorectal cancer after surgery
Exclusion Criteria:
- History of other malignancies or serious medical conditions
- Inability to provide independent informed consent
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
China-Japan Friendship Hospital
Address:
City:
Beijing
Zip:
100029
Country:
China
Status:
Recruiting
Contact:
Last name:
Yongliang Sun, MD
Email:
sunyongliang1982@hotmail.com
Facility:
Name:
Peking Union Medical College Hospital
Address:
City:
Beijing
Zip:
100730
Country:
China
Status:
Recruiting
Contact:
Last name:
Yilei Mao, MD PhD
Phone:
8600-010-69156042
Email:
pumch-liver@hotmail.com
Contact backup:
Last name:
Hang Sun, MD
Phone:
8600-15626041366
Email:
hangsunkcs@163.com
Start date:
December 1, 2022
Completion date:
September 30, 2024
Lead sponsor:
Agency:
Peking Union Medical College Hospital
Agency class:
Other
Source:
Peking Union Medical College Hospital
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05955092
